Koninklijke Philips Nv Revenue Growth Rates (PHG), Current and Historic Growth - CSIMarket
CSIMarket
 


Koninklijke Philips Nv  (NYSE: PHG)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

PHG's Revenue Growth by Quarter and Year

Koninklijke Philips Nv's Revenue results by quarter and year




PHG Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December 19,974.08
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 19,974.08

PHGs Annual Revenue
Koninklijke Philips Nv's Revenue in the fiscal year 2025 $ 19,974.08 millions
Koninklijke Philips Nv's Revenue in the fiscal year 2024 $ 20,183.52 millions
Koninklijke Philips Nv's Revenue in the fiscal year 2023 $ 20,349.28 millions
Koninklijke Philips Nv's Revenue in the fiscal year 2022 $ 19,966.24 millions
Koninklijke Philips Nv's Revenue in the fiscal year 2021 $ 19,214.72 millions




PHG Revenue fourth quarter 2024 Y/Y Growth Comment
Koninklijke Philips Nv reported decrease in Revenue in the fourth quarter 2024 by -1.04% to $ 19,974.08 millions, from the same quarter in 2023.
The decrease in the fourth quarter 2024 Koninklijke Philips Nv's Revenue compares unfavorably to the Company's average Revenue decrease of -0.06%.

Looking into fourth quarter 2024 results within Medical Laboratories industry 26 other companies have achieved higher Revenue growth. While Koninklijke Philips Nv' s Revenue decline of -1.04% ranks overall at the positon no. 2816 in the fourth quarter 2024.




PHG Revenue ( Y/Y Growth %) 2024
2023 2022 2021
4th Quarter December -1.04 % -0.81 % 1.92 % 3.91 %
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   -1.04 % -0.81 % 1.92 % -

Financial Statements
Koninklijke Philips Nv's fourth quarter 2024 Revenue $ 19,974.08 millions PHG's Income Statement
Koninklijke Philips Nv's fourth quarter 2023 Revenue $ 20,183.52 millions Quarterly PHG's Income Statement


PHG Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   -1.04 % -0.81 % 1.92 % -




Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #27
Healthcare Sector #425
Overall #2816

Revenue Y/Y Growth Statistics
High Average Low
7.51 % -0.06 % -12.18 %
(Dec 31 2019)  
Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #27
Healthcare Sector #425
Overall #2816
Revenue Y/Y Growth Statistics
High Average Low
7.51 % -0.06 % -12.18 %
(Dec 31 2019)  

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Koninklijke Philips Nv's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PHG's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PHG's IV. Quarter Q/Q Revenue Comment


Koninklijke Philips Nv's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)
12 Months Ending
(Dec 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 19,974.08 $ 20,183.52 $ 20,349.28 $ 19,966.24 $ 19,214.72
Y / Y Revenue Growth (TTM) -1.04 % -0.81 % 1.92 % 3.91 % -12.18 %
Year on Year Revenue Growth Overall Ranking # 3157 # 0 # 3092 # 0 # 0
Seqeuential Revenue Change (TTM) -1.04 % -0.81 % 1.92 % 3.91 % -12.18 %
Seq. Revenue Growth (TTM) Overall Ranking # 3157 # 0 # 3089 # 0 # 0


Cumulative Revenue growth Comment
Koninklijke Philips Nv's cumulative 12 months Revenue continue to decrease, but on the faster rate at -1.04% year on year, at Dec 31 2025 compare to the -0.81% decrease at Dec 31 2024. If the Koninklijke Philips Nv's fiscal year would end at Dec 31 2025, annual Revenue would be $19,974 millions.

In the Healthcare sector 422 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3157.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 29
Healthcare Sector # 423
Overall # 3157

Revenue TTM Y/Y Growth Statistics
High Average Low
7.51 %
0.29 %
-12.18 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 423
S&P 500 # 3157
Cumulative Revenue growth Comment
Koninklijke Philips Nv's cumulative 12 months Revenue continue to decrease, but on the faster rate at -1.04% year on year, at Dec 31 2025 compare to the -0.81% decrease at Dec 31 2024. If the Koninklijke Philips Nv's fiscal year would end at Dec 31 2025, annual Revenue would be $19,974 millions.

In the Healthcare sector 422 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3157.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 29
Healthcare Sector # 423
Overall # 3157

Revenue TTM Y/Y Growth Statistics
High Average Low
7.51 %
0.29 %
-12.18 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 423
S&P 500 # 3157




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PHG's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Ardent Health Inc -0.08%$ -0.075 millions
Chemed Corporation-0.10%$ -0.103 millions
Embecta Corp -0.15%$ -0.153 millions
Bruker Corporation-0.24%$ -0.245 millions
Vaso Corporation-0.38%$ -0.376 millions
Bio techne Corp-0.54%$ -0.542 millions
Lftd Partners Inc -0.76%$ -0.763 millions
Xtant Medical Holdings Inc -0.82%$ -0.821 millions
Charles River Laboratories International inc -0.83%$ -0.830 millions
Koninklijke Philips Nv-1.04%$ -1.038 millions
Evotec Se-1.08%$ -1.078 millions
Pfizer Inc-1.16%$ -1.160 millions
Adapthealth Corp -1.21%$ -1.209 millions
Avantor Inc -1.36%$ -1.364 millions
Alpha Teknova Inc -1.42%$ -1.422 millions
Skinhealth Systems Inc -1.57%$ -1.569 millions
Pediatrix Medical Group Inc -1.71%$ -1.711 millions
Integra Lifesciences Holdings Corp-1.74%$ -1.744 millions
Edap Tms Sa-1.78%$ -1.783 millions
Vivos Therapeutics Inc -2.18%$ -2.178 millions
Absci Corp-2.26%$ -2.256 millions
Prestige Consumer Healthcare Inc -2.30%$ -2.303 millions
Perrigo Company Plc-2.52%$ -2.521 millions
Bionano Genomics Inc -2.60%$ -2.597 millions
Haemonetics Corporation-2.64%$ -2.636 millions
Amphastar Pharmaceuticals Inc -2.79%$ -2.790 millions
Strata Skin Sciences Inc-2.97%$ -2.966 millions
Plus Therapeutics Inc -3.19%$ -3.187 millions
Harvard Bioscience Inc -3.23%$ -3.226 millions
Brookdale Senior Living Inc -3.44%$ -3.439 millions


About Koninklijke Philips Nv Revenue Growth Rates (PHG), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Koninklijke Philips Nv (CIK 313216).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-009470
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Koninklijke Philips Nv’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.